Dias KB, Flores APC, Hildebrand LC, de Oliveira MG, Lamers ML, Rados PV, Magnusson AS, Filho MS. Non-muscle myosin II as a predictive factor in head and neck squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2019 May 1;24 (3):e346-53.
doi:10.4317/medoral.22898
http://dx.doi.org/doi:10.4317/medoral.22898
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
1. Bezerra NV, Leite KL, de Medeiros MM, Martins ML,
Cardoso AM, Alves PM, et al. Impact of the anatomical location, alcoholism
and smoking on the prevalence of advanced oral cancer in Brazil. Medicina oral, patologia oral y
cirugia bucal. 2018;23:e295-e301. |
|
|
|
|
|
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E,
Forman D. Global cancer statistics. CA: a cancer journal for
clinicians. 2011;61:69-90. |
|
|
|
|
|
3. Yanamoto S, Kawasaki G, Yamada S, Yoshitomi I,
Kawano T, Yonezawa H, et al. Isolation and characterization of cancer
stem-like side population cells in human oral cancer cells. Oral
oncology. 2011;47:855-60. |
|
|
|
|
|
4. Painter KJ, Armstrong NJ, Sherratt JA. The impact
of adhesion on cellular invasion processes in cancer and development. Journal
of theoretical biology. 2010;264:1057-67. |
|
|
|
|
|
5. Vicente-Manzanares
M, Ma X, Adelstein RS, Horwitz AR. Non-muscle
myosin II takes centre stage in cell adhesion and migration. Nature reviews
Molecular cell biology. 2009;10:778-90. |
|
|
|
|
|
6. Hildebrand LC, Carvalho AL, Lauxen IS, Nor JE,
Cerski CT, Sant'Ana Filho M. Spatial distribution of cancer stem cells in
head and neck squamous cell carcinomas. Journal of oral pathology & medicine:
official publication of the International Association of Oral Pathologists
and the American Academy of Oral Pathology. 2014;43:499-506. |
|
|
|
|
|
7. Flores APC, Dias KB, Hildebrand LC, Oliveira MG,
Lamers ML, Sant'Ana Filho M. Focal adhesion kinases in head and neck squamous
cell carcinoma. Journal of oral pathology & medicine : official
publication of the International Association of Oral Pathologists and the
American Academy of Oral Pathology. 2018;47:246-52. |
|
|
|
|
|
8. Bryne M, Koppang HS, Lilleng R, Kjaerheim A.
Malignancy grading of the deep invasive margins of oral squamous cell
carcinomas has high prognostic value. The Journal of pathology. 1992;166:375-81. |
|
|
|
|
|
9. Edge SB, Compton CC. The American Joint Committee
on Cancer: the 7th edition of the AJCC cancer staging manual and the future
of TNM. Annals
of surgical oncology. 2010;17:1471-4. |
|
|
|
|
|
10. Chang JH, Wu CC, Yuan KS, Wu ATH, Wu SY.
Locoregionally recurrent head and neck squamous cell carcinoma: incidence,
survival, prognostic factors, and treatment outcomes. Oncotarget. 2017;8:55600-12. |
|
|
|
|
|
11. Brown LM, Check DP, Devesa SS. Oral cavity and
pharynx cancer incidence trends by subsite in the United States: changing
gender patterns. Journal
of oncology. 2012;2012:649498. |
|
|
|
|
|
12. Taghavi N, Yazdi I. Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Archives of Iranian medicine. 2015;18:314-9. |
|
|
|
|
|
13. El-Mofty SK. Histopathologic risk factors in
oral and oropharyngeal squamous cell carcinoma variants: an update with
special reference to HPV-related carcinomas. Medicina oral, patologia oral y
cirugia bucal. 2014;19:e377-85. |
|
|
|
|
|
14. Huang SH, O'Sullivan B. Overview of the 8th
Edition TNM Classification for Head and Neck Cancer. Current treatment
options in oncology. 2017;18:40. |
|
|
|
|
|
15. Sterz CM, Kulle C, Dakic B, Makarova G, Bottcher
MC, Bette M, et al. A basal-cell-like compartment in head and neck squamous
cell carcinomas represents the invasive front of the tumor and is expressing
MMP-9. Oral
oncology. 2010;46:116-22. |
|
|
|
|
|
16. Jacobs K, Van Gele M, Forsyth R, Brochez L,
Vanhoecke B, De Wever O, et al. P-cadherin counteracts myosin II-B function:
implications in melanoma progression. Molecular cancer. 2010;9:255. |
|
|
|
|
|
17. Ouderkirk JL, Krendel M. Non-muscle myosins in
tumor progression, cancer cell invasion, and metastasis. Cytoskeleton. 2014;71:447-63. |
|
|
|
|
|
18. Sturgis EM, Cinciripini PM. Trends in head and
neck cancer incidence in relation to smoking prevalence: an emerging epidemic
of human papillomavirus-associated cancers? Cancer. 2007;110:1429-35. |
|
|
|
|
|
19. Kim L, King T, Agulnik M. Head and neck cancer: changing epidemiology and public health implications. Oncology (Williston Park). 2010;24:915-9, 24. |
|
|
|
|
|
20. Carrard VC, Filho MS, Rados PV, Chaves AC,
Lauxen Ida S. Quantification of silver-staining nucleolar organizer region in
epithelial cells of tongue of mice after exposure to, or intake of,
alcohol. Alcohol. 2004;34:233-8. |
|
|
|
|
|
21. Helfman DM, Pawlak G. Myosin light chain kinase
and acto-myosin contractility modulate activation of the ERK cascade
downstream of oncogenic Ras. Journal of cellular biochemistry. 2005;95:1069-80. |
|
|
|
|
|
22. Yam JW, Chan KW, Hsiao WL. Suppression of the
tumorigenicity of mutant p53-transformed rat embryo fibroblasts through
expression of a newly cloned rat nonmuscle myosin heavy chain-B. Oncogene. 2001;20:58-68. |
|
|
|
|
|
23. Turati F, Garavello W, Tramacere I, Pelucchi C,
Galeone C, Bagnardi V, et al. A meta-analysis of alcohol drinking and oral
and pharyngeal cancers: results from subgroup analyses. Alcohol and alcoholism.
2013;48(1):107-18. |
|
|
|
|
|
24. Brabletz T, Jung A, Spaderna S, Hlubek F,
Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of
malignant tumour progression. Nature reviews Cancer. 2005;5:744-9. |
|
|
|
|
|
25. Vicente-Manzanares M, Newell-Litwa K, Bachir AI,
Whitmore LA, Horwitz AR. Myosin IIA/IIB restrict adhesive and protrusive
signaling to generate front-back polarity in migrating cells. The Journal of
cell biology. 2011;193:381-96. |
|
|
|
|
|
26. Maeda
J, Hirano T, Ogiwara A, Akimoto S, Kawakami T, Fukui Y, et al. Proteomic analysis of stage I primary lung adenocarcinoma aimed at
individualisation of postoperative therapy. British journal of
cancer. 2008;98:596-603. |
|
|
|
|
|
27. Liu
D, Zhang L, Shen Z, Tan F, Hu Y, Yu J, et al. Clinicopathological
significance of NMIIA overexpression in human gastric cancer. International
journal of molecular sciences. 2012;13:15291-304. |
|
|
|
|
|
28. Schramek D, Sendoel A, Segal JP, Beronja S,
Heller E, Oristian D, et al. Direct in vivo RNAi screen unveils myosin IIa as
a tumor suppressor of squamous cell carcinomas. Science. 2014;343:309-13. |
|
|
|
|
|
29. Conti MA, Saleh AD, Brinster LR, Cheng H, Chen
Z, Cornelius S, et al. Conditional deletion of nonmuscle myosin II-A in mouse
tongue epithelium results in squamous cell carcinoma. Scientific
reports. 2015;5:14068. |
|
|
|
|
|
30. Daniels MJ, Wang Y, Lee M, Venkitaraman AR.
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility
protein BRCA2. Science. 2004;306:876-9. |
|
|
|
|
|
31. Jana SS, Kawamoto S, Adelstein RS. A specific
isoform of nonmuscle myosin II-C is required for cytokinesis in a tumor cell
line. The Journal of biological chemistry. 2006;281:24662-70. |
|
|
|
|
|
32. Takaoka M, Saito H, Takenaka K, Miki Y,
Nakanishi A. BRCA2 phosphorylated by PLK1 moves to the midbody to regulate
cytokinesis mediated by nonmuscle myosin IIC. Cancer
research. 2014;74:1518-28. |
|